day 2 agenda

Scientific Program
Day -2: July (20, 2023)
Keynote Talks
09:00-9:30	Title: Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals
	Keisuke Fukuchi, DAIICHI SANKYO CO., LTD., Japan
9:30-10:00	Title: Cytochrome c Acetylation in Prostate Cancer: Warburg Effect and Evasion of Apoptosis
	Maik Huettemann, Wayne State University, United States
Morning Session Session Chairs: Mohamed El-Tanani, Al-Ahliyya Amman, Jordan (&) Debdulal Roy, Swansea University, United Kingdom
10:00-10:20	Title: Quantum dots based in-vitro co-culture cancer model for identification of rare cancer cell heterogeneity
	Anupalli Roja Ranii, Osmania University, India
10:20-10:40	Title: Comparison of the functional state and motor skills of patients after cerebral hemisphere, ventricular system, and cerebellopontine angle tumor surgery
	Stanislaw Krajewski, University of Bydgoszcz, Poland
10:40-11:00	Title: Design and standard utilization of safety devices for the radiation treatment management of heavy patients
	David Kanchaveli, Memorial Sloan Kettering Cancer Center, United States
11:00-11:20	Title: LOWER 24- MONTH RELATIVE SURVIVAL AMONG BLACK PATIENTS WITH NON- HODGKIN’S LYMPHOMA: AN ANALYSIS OF THE SEER DATA 1997-2015
	Maria J Nieto, Northwell Health Cancer Institute, United States
11:20-11:40	Title: Could alkalization of the acidic tumor microenvironment contribute to the outcome of cancer treatment? Meaning and significance of “alkalization therapy for Cancer
	Reo Hamaguchi, Japanese Society on Inflammation and Metabolism in Cancer, Japan
11:40-12:00	Title: New gold (III) cyanide complex TGS121 induces ER stress, proteasome inhibition and death of Ras-hyperactivated cells
	Izabela Mlynarczuk-Bialy, Warsaw Medical University, Poland
12:00-12:20	Title: Drugging the undruggable: Small molecule inhibitors against the RNA Binding protein hnRNP A18 to simultaneously Inhibit Protein Translation and an Immune Checkpoint in Cancers
	France Carrier, University of Maryland, Baltimore, United States
12:20-12:40	Title: A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
	Mariusz Madej, Crown Bioscience, Netherlands
12:40-13:00	Title: Pediatric Spinal Hemangioblastomas: Clinical Features and Surgical Outcomes of 39 Case
	Wenqing Jia, Beijing Tiantan Hospital, Capital Medical University, China
13:00-14:00	Lunch Break
Afternoon Session                    Session Chairs: Izabela Mlynarczuk-Bialy, Warsaw Medical University, Poland & Anupalli Roja Ranii, Osmania University, India
14:00-14:20	Title: Novel de Novo CDC42 Gene Defect causes Pancytopenia, Recurrent Infection, Poor Wound Healing, Heterotopia of the Brain: expanding the phenotype spectrum
	Wafaa Mohammed AL Suwairi, KAMC-NGHA, Saudi Arabia
14:20-14:40	Title: Associations between nutrition risk scores and sarcopenia in gastrointestinal cancer patients: A cross-sectional study
	Bo Gao, Nanjing University, China
14:40-15:00	SPEAKER SLOT AVAILABLE
15:00-15:20	Title: A randomized phase II study of 5-aminolevulinic acid hydrochloride and sodium ferrous citrate for the prevention of nephrotoxicity induced by cisplatin-based chemotherapy of lung cancer
	Motowo Nakajima, SBI Pharmaceuticals, Japan
15:20-15:40	Title: Stromal Factors on Prostate Cancer Differentiation
	Alvin Y Liu, University of Washington, United States
15:40-16:00	Title: Electrochemical immunosensors for detection and monitoring of breast and lung cancers
	Iva Chianella, Cranfield University, United Kingdom
16:00-16:10	Refreshment Break
16:10-16:30	Title: Evolution of myeloma treatment patterns during and after COVID-19 pandemic period
	Natalia Neparidze, Yale University/ yale Cancer Center, United States
16:30-16:50	Title: Correlation between serum cox 2 levels and development of hand foot syndrome     with capecitabine – an exploratory analysis from the d-torch study
	Akhil Santhosh, All India Institute of Medical Sciences, India
16:50-17:10	Title: The function and mechanism of lncRNA ARHGAP5-AS1 on the Progression of Triple-negative breast cancer
	Qian Zhao, Shanghai JiaoTong University School of Medicine, China
17:10-17:30	SPEAKER SLOT AVAILABLE
Day-2 Concludes
Note: This is the tentative program only and the timings may be subject to change
Conference Hotel: Leonardo Royal Hotel Frankfurt Mailander Str. 1, 60598 Frankfurt am Main, Germany
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com

Virtual Agenda

Scientific Program
Day -1: July (19, 2023)
Virtual Presentations (Time zone: CET)
11:00-11:20	Title: Development of a breast cancercase management information platform(BC-CMIP)module based on patient-perceived value
	Yinyin Liang,  The Second Affiliated Hospital of Chongqing Medical University, China
11:20-11:40	Title: MKL-1 Induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA mediated glycolysis
	Yuan Wu, Huazhong University of Science and Technology, China
11:40-12:00	SPEAKER SLOT AVAILABLE
12:00-12:20	Title: A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors
	Huang Qing, Xiamen Huaxia University, China
12:20-12:40	Title: Precise minimally invasive treatment of gastric cancer beyond the indications of endoscopic treatment with novel combined endoscopic and laparoscopic surgery
	Guiyong Peng, Chongqing Southwest Hospita, China
12:40-13:00	Title: AI-assisted Laser-Induced Plasma Spectroscopy for Real-time, In Vivo Skin Cancer detection
	Sung Hyun Pyun, Speclipse, Inc., Korea
13:00-13:20	Title: Intrinsic and chemically-induced daughter number variations in cancer
	Hong XUE,  Hong Kong University of Science and Technology, China
13:20-13:40	Title: Assessment of breast cancer risk factors among pre and post-menopausal women
	Ritu Yadav, Maharshi Dayanand University, India
13:40-14:00	Title: Has the COVID-19 pandemic affected the psychological state of Arab cancer patients?
	Norah Abdullah Bazek Madkhali, Jazan university, Saudi Arabia
14:00-14:20	Title: Antibiotic prophylaxis in breast surgery a metaanalysis to identify the optimal strategy to reduce infection rates in breast surgery
	Bader Alali,  Mubarak Al Kabeer Hospital, Kuwait
14:20-14:40	Title: Gluten Exorphins Promote Tumorigenesis in In Vitro Models of Human Lymphoma and Carcinoma
	Federico Manai, University of Pavia, Italy
14:40-15:00	Title: Bromodomain-encoding epigenetic factors as potent regulators of cancer stemness
	Patrycja Czerwinska, Poznan University of Medical Sciences, Poland
15:00-15:20	Title: Patients’ pathways to cancer care in Tanzania: documenting and addressing social inequalities in reaching a cancer diagnosis
	Cristina Santos, The Open University, United Kingdom
15:20-15:40	Title: Effects of Bortezomib on the tumor immune microenvironment: Results from salivary gland carcinoma and mesothelioma mouse models
	Camilla Palumbo, University of Rome "Tor Vergata", Italy
15:40-16:00	Title: Characterization of ovarian cancer symptoms in women without ovarian cancer
	Lindsay Beechem, University of Kentucky College of Medicine, United States
16:00-16:20	Title: The humanized monoclonal ant CCR5 antibody blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
	Richard G Pestell, Baruch S Blumberg Institute, United States
16:20-16:40	Title: Comparing transcriptomic profiles from seven cell lines to elucidate liver metastatic potential
	Lindsay R. Dresang, University of Wisconsin-Stevens Point, United States
16:40-17:00	Title: Anti-prostate cancer bone metastasis Radium223-based therapies a computational/experimental integrated approach
	Stefano Casarin, Houston Methodist Research Institute, United States
17:00-17:20	Title: Evaluation of Alternatives to Logrank test in Immuno-Oncology Trials under Delayed Treatment Effect A Retrospective Analysis in Patients Treated with Anti-PD1/PD-L1 Agents across Solid Tumors
	Pralay Mukhopadhyay, Otsuka America Pharmaceuticals Incorporated, United States
17:20-17:40	Title: Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients.
	Olayinka Adebayo, Johnson & Johnson, United States
17:40-18:00	Title: Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network HospitalPeer Physician Coaching Between a Cancer Genetics Service and Community OncologistsPeer Physician Coaching Between a Cancer Genetics Service and Community Oncologists
	Marianne Dubard-Gault, University of Washington, United States
Day-1 Concludes
Note: This is the tentative program only and the timings may be subject to change
Conference Hotel: Leonardo Royal Hotel Frankfurt Mailander Str. 1, 60598 Frankfurt am Main, Germany
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com

Virtual Agenda

Scientific Program
Day -2: July (20, 2023)
Virtual Presentations (Time zone: CET)
11:00-11:20	Title: Anti-transcriptional intermediary factor 1-γ antibody in cancer-assoicated myositis
	Yoshinori Tanino, Fukushima Medical University, Japan
11:20-11:40	SPEAKER SLOT AVAILABLE
11:40-12:00	Title: Assessment of B7-H3 as a potent biomarker for predicting the radiosensitivity of IDH-wildtype Glioblastoma
	Hui Wu, Affiliated Cancer Hospital of Zhengzhou University, China
12:00-12:20	Title: Application of Cytochrome C-Related Genes in Prognosis and Treatment Prediction of Lung Adenocarcinoma
	Min Tang, Chongqing General Hospital, China
12:20-12:40	Title: TAPE-seq: A Cell-Based Method for Predicting Genome-Wide Off-Target Effects of Prime Editor
	Jungjoon Lee, Toolgen, Korea
12:40-13:00	Title: Combination strategies to maximize the benefits of cancer immunotherapy
	Shaoming Zhu, Beijing Chao-Yang Hospital, China
13:00-13:20	Title: INTEGRATION OF CONSOLIDATION CHEMOTHERAPY IN CERVICAL CANCER – THINKING BEYOND
	Fatema Nedham, BDF hospital, Bahrain
13:20-13:40	Title: Mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells, and is indispensable for BT-20 cells in vitro
	Alexander Weiss &Andreas Andric, University of Innsbruck, Austria
13:40-14:00	Title: Revolutionizing Cancer Care - Personalized Treatment powered by comprehensive Tumor Profiling in NEBC
	Dörthe Schaffrin-Nabe, Praxis für Hämatologie und Onkologie, Germany
14:00-14:20	Title: Impact of Doxorubicin on Cell-Substrate Topology
	Herbert Schneckenburger,  Schneckenburger, Germany
14:20-14:40	Title: The antiproliferative effect of cannabidiol in cancer cells is modulated by its physical state and by growth factors
	Alessia D'Aloia, University of Milano-Bicocca, Italy
14:40-15:00	Title: Investigating the role of non-canoncial Wnt planar cell polarity during normal prostate tissue homeostasis and prostate cancer
	Helen Pearson, Cardiff University, United Kingdom
15:00-15:20	Title: SMAD4 governs a feedforward regulation of the TGF-β-effects in CD8 T cells that contributes to preventing chronic intestinal inflammation, a fertile soil for cancer
	Saidi Soudja, Centre de Recherche en cancérologie de Lyon, France
15:20-15:40	Title: Measurement of Irritability in Cancer Patients
	Amy Zhang, Case Western Reserve University, United States
15:40-16:00	Title: Role of timing of steroid use on clinical outcomes of immune checkpoint inhibitor – A population based study
	Nikita Nikita, Thomas Jefferson University, United States
16:00-16:20	Title: The interplay between apurinic/apyrimidinic endonuclease 1 (APE1) and DNA G-quadruplex (G4) in regulating triple-negative breast cancer (TNBC) metastasis.
	Kishor K. Bhakat, University of Nebraska Medical Center, United States
16:20-16:40	Title: Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
	Elnaz Naderi, Columbia University Medical center, United states
16:40-17:00	Title: Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma
	Scott A. Weed, West Virginia University Cancer Institute, United States
17:00-17:20	Title: Tissue transglutaminase: a new target at the interface with the ovarian cancer stem cell niche
	Salvatore Condello, Indiana University School of Medicine, United States
17:20-17:40	Title: ChoK-full of potential: Choline kinase in B cell and T cell malignancies
	Ping Xie, Rutgers University, United States
17:40-18:00	Title: Interfering with Lipid Metabolism through Targeting CES1 Sensitizes Hepatocellular Carcinoma for Chemotherapy
	Kai Sun, University of Texas Health Science Center, United States
18:00-18:20	Title:Genomic alterations associated with onset and development of angioimmunoblastic T-cell lymphoma and concomitant hematologic neoplasms
	Shuhua Cheng, Icahn School of Medicine at Mount Sinai, United States
18:20-18:40	Title: New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitors
	Ahmad Sufian Bin Ab Rahman, Linear Clinical Research, Perth, Australia
18:40-19:00	SPEAKER SLOT AVAILABLE
Day-2 Concludes
Note: This is the tentative program only and the timings may be subject to change
Conference Hotel: Leonardo Royal Hotel Frankfurt Mailander Str. 1, 60598 Frankfurt am Main, Germany
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com